Mobile

A Study Comparing ABT-494 Monotherapy to Methotrexate (MTX) Monotherapy in Subjects with Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-003376-75

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To compare the safety and efficacy (signs and symptoms) of ABT-494 monotherapy versus MTX in MTX-inadequate response (MTX-IR) subjects with moderately to severely active rheumatoid arthritis (RA). • To evaluate the long-term safety, tolerability, and efficacy of ABT-494 in subjects with RA.

Critère d'inclusion

  • Moderately to Severely Active Rheumatoid Arthritis (RA)

Liens